A Single Measure of Cancer Burden Combining Incidence with Mortality Rates for Worldwide Application

Randomized Control Study of Nedaplatin or Cisplatin Concomitant with Other Chemotherapy in the Treatment of Advanced Non-small Cell Lung Cancer

“…Incidences of lung cancer in China have been increasingly more serious for the past few years, in which NSCLC accounts for>80%, including large cell carcinoma, adeno-carcinoma and squamous carcinoma (Govindan et al, 2006;Liu et al, 2013;Kim et al, 2014). Surgery is one of the optimal therapeutic methods for early treatment, but it is difficult to perform because there is no specific or obvious clinical symptom in early stage (Yu et al, 2013;Oven Ustaalioglu et al, 2013;Mandal et al, 2013).…”

Expression of Tumor Necrosis Factor Receptor-associated Factor 6 in Lung Cancer Tissues

“…However, lung cancer burden was highest for men in more developed regions compared with that in lower developed regions (Kim et al, 2014). According to the statistics, 224, 210 new cases will be diagnosed as lung cancer and 159, 260 will die from it in the United States in 2014 (Siegel et al, 2014).…”

CD3+CD4+and CD3+CD8+Lymphocyte Subgroups and their Surface Receptors NKG2D and NKG2A in Patients with Non-small Cell Lung Cancer

“…Lung cancer is the primary risk factor of malignant tumor-associated death across the world in the 21th century with increasingly rising morbidity and mortality, which has no significant clinical characteristic and symptom as well as specific detection method in its early stage (Kim et al, 2014;Deng et al, 2014). Therefore, patients with lung cancer are always in advanced ones when diagnosed with highly limited recovery rate by systematic treatment, for which early diagnosis and treatment become one of the topics in studying lung cancer (Huang et al, 2013;.…”